Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
121 hedge funds and large institutions have $708M invested in Taro Pharmaceutical Industries Ltd. in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 16 closing their positions.
94% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 16
21% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 34
14% more funds holding
Funds holding: 106 → 121 (+15)
3% more capital invested
Capital invested by funds: $689M → $708M (+$19M)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
76% less call options, than puts
Call options by funds: $3.66M | Put options by funds: $15.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$40.5M |
| 2 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$27.5M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$10.9M |
| 4 |
KA
Kerrisdale Advisers
Miami,
Florida
|
+$10.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$37.8M |
| 2 |
ICM
ISZO Capital Management
New York
|
-$16.4M |
| 3 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$5.03M |
| 4 |
Millennium Management
New York
|
-$4.61M |
| 5 |
AP
AHL Partners
London,
United Kingdom
|
-$4.51M |
TARO Hedge Fund Activity: Q3 2015 in Review
121 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2015, worth a combined $708M — up 2.8% from $689M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new TARO positions and 16 closed out — a net gain of 15 holders — while 41 added to existing stakes and 34 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $40.5M. The largest seller was Raging Capital Management, exiting entirely with an estimated $37.8M sold.
- 121 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2015, up from 106 in Q2 2015.
- Funds reported $708M of Taro Pharmaceutical Industries Ltd. stock for Q3 2015, up 2.8% quarter-over-quarter.
- 31 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2015 and 16 closed out, a net change of +15 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2015 was Schroder Investment Management Group, an estimated $40.5M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2015 was Raging Capital Management, an estimated $37.8M sold.
Based on aggregated 13F filings for Q3 2015.